— Know what they know.
Not Investment Advice

NSISBC.XD DXE

Novonesis (Novozymes) B
1W: -1.6% 1M: -7.6% 3M: -2.5% YTD: +7.9% 1Y: -0.6%
kr 422.00 ($63.27)
+4.60 (+1.10%)
 
Weekly Expected Move ±3.1%
kr 391 kr 404 kr 417 kr 431 kr 444
DXE · Basic Materials · Chemicals - Specialty · Tech Score Sell · Power 37 · kr 116.0B mcap

📊 Key Metrics

TTM
kr 31B
Revenue
+49.0% YoY
kr 5B
Net Income
+248.1% YoY
kr 4B
Free Cash Flow
+0.7% YoY
56.7%
Gross Margin
23.8%
Op. Margin
17.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE5.8%
ROA4.1%
ROIC5.0%

Valuation

P/E39.8
P/B2.3
EV/EBITDA17.1

Leverage

Debt/Equity0.29
Current Ratio1.67
Interest Cov.20.2x

Quality Scores

Piotroski F5/9
Altman Z4.03
Beneish M-2.36

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms